DK0580644T3 - 1,3,4-trisubstituted piperidine derivatives, preparation and use thereof - Google Patents

1,3,4-trisubstituted piperidine derivatives, preparation and use thereof

Info

Publication number
DK0580644T3
DK0580644T3 DK92907778.2T DK92907778T DK0580644T3 DK 0580644 T3 DK0580644 T3 DK 0580644T3 DK 92907778 T DK92907778 T DK 92907778T DK 0580644 T3 DK0580644 T3 DK 0580644T3
Authority
DK
Denmark
Prior art keywords
preparation
piperidine derivatives
trisubstituted
trisubstituted piperidine
compounds
Prior art date
Application number
DK92907778.2T
Other languages
Danish (da)
Inventor
Gerd Steiner
Hans Peter Hofmann
Liliane Unger
Hans-Juergen Teschendorf
Berthold Behl
Rudolf Binder
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK0580644T3 publication Critical patent/DK0580644T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The description relates to compounds of formula (I) in which A-B-D, R?1, R?2, R?3 and n have the meanings given in the specification, and their production. The compounds are suitable for the treatment of diseases.
DK92907778.2T 1991-04-16 1992-04-04 1,3,4-trisubstituted piperidine derivatives, preparation and use thereof DK0580644T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4112353A DE4112353A1 (en) 1991-04-16 1991-04-16 1,3,4-TRISUBSTITUTED PIPERIDINE DERIVATIVES, THEIR PRODUCTION AND USE

Publications (1)

Publication Number Publication Date
DK0580644T3 true DK0580644T3 (en) 1995-08-28

Family

ID=6429675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92907778.2T DK0580644T3 (en) 1991-04-16 1992-04-04 1,3,4-trisubstituted piperidine derivatives, preparation and use thereof

Country Status (8)

Country Link
EP (1) EP0580644B1 (en)
JP (1) JPH06506920A (en)
AT (1) ATE124398T1 (en)
CA (1) CA2107665A1 (en)
DE (2) DE4112353A1 (en)
DK (1) DK0580644T3 (en)
ES (1) ES2073919T3 (en)
WO (1) WO1992018480A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219973A1 (en) * 1992-06-19 1993-12-23 Basf Ag N-substituted azabicycloheptane derivatives, their preparation and use
DE4341402A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted azabicycloheptane derivatives, their preparation and use
DE4341403A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted 3-azabicycloalkane derivatives, their preparation and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655533A (en) * 1970-11-12 1972-04-11 Allied Chem Zinc electroplating process and acidic zinc fluoborate electrolyte therefor
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
CA1337418C (en) * 1988-03-28 1995-10-24 Engelbert Ciganek 4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof

Also Published As

Publication number Publication date
WO1992018480A1 (en) 1992-10-29
JPH06506920A (en) 1994-08-04
EP0580644A1 (en) 1994-02-02
ATE124398T1 (en) 1995-07-15
DE4112353A1 (en) 1992-10-22
ES2073919T3 (en) 1995-08-16
CA2107665A1 (en) 1992-10-17
EP0580644B1 (en) 1995-06-28
DE59202744D1 (en) 1995-08-03

Similar Documents

Publication Publication Date Title
NO20075065L (en) Use of isoflavone compounds to treat heart disease
ATE65994T1 (en) INSECTICIDES PYRAZOLINES.
MY106280A (en) Novel benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use.
MX9604378A (en) Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments, as well as intermediate products thereof.
PT662958E (en) DERIVATIVES OF 1- (2-OXO-ACETYL) -PIPERIDINE-2-CARBOXYLIC ACID AS SENSITIZERS OF MULTIPLE PHARMACEUTICAL CANCER RESISTANT CELLS
NO952132L (en) Pharmacologically active pyridine derivatives and their preparation
NO306346B1 (en) N-substituted azabicycloalkane derivatives, their use and pharmaceutical preparation
ES8203888A1 (en) 4-Heterocylic substituted dihydropyridines, processes for preparing them, their therapeutical use and their preparation.
NO933200L (en) Substituted cyclohexane derivatives, process for their preparation and use of the compounds for the treatment of diseases
NO922133D0 (en) SUBSTITUTED DIAMINOPHALIMIDES AND ANALOGS
DK0450420T3 (en) Heterocyclic Substituted Dihydropyridines, Methods for their Preparation and Use in Drugs
NO20010940L (en) TAN-1057 derivatives
NO306400B1 (en) N-Substituted Azabicycloheptane Derivatives, Their Use and Pharmaceutical Preparation
DK192988A (en) DIHYDROPYRIDINAMIDES, THEIR PREPARATION AND USE
NO970573D0 (en) Yliden compounds and their preparation
DK0580644T3 (en) 1,3,4-trisubstituted piperidine derivatives, preparation and use thereof
ATE177424T1 (en) N-SUBSTITUTED NAPHTHALIMIDES, THEIR PRODUCTION AND USE
NO991581L (en) N- (benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and use in therapeutic agents
ES2043515A1 (en) 1-Diphenylmethylpiperazine derivatives, their preparation, their use as medicines.
DK0580624T3 (en) New Cytarabine Derivatives, Preparation and Use thereof
NO911798L (en) 3'-DEAMINO-4'-DEOXY-4'-AMINO-8-FLUORANTRACYCLINES AND THEIR PREPARATION.
ATE87314T1 (en) PLATINUM MEDICINES.
SE9803280D0 (en) Novel compounds
SE9803279D0 (en) Novel compounds
MX9704796A (en) Novel peptides, their production and use.